Hyaluronan synthesis and degradation in cartilage and bone

Cellular and Molecular Life Sciences

Volumn 65, Issue 3, 2008, Pages 395-413

  Bastow, E R ^a   Byers, S ^b   Golub, S B ^a   Clarkin, C E ^c   Pitsillides, A A ^c   Fosang, A J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Bone; Cartilage; Growth plate; Hyaluronan; Hyaluronan synthase; Hyaluronidase; Limb morphogenesis; Skeletal development

Indexed keywords

AGGRECAN; HYALURONIC ACID;

BIOSYNTHESIS; BONE; BONE DEVELOPMENT; BONE GROWTH; BONE REMODELING; CARTILAGE; CELL MIGRATION; DEPOLYMERIZATION; HUMAN; JOINT CAVITY; LIMB DEVELOPMENT; MESENCHYME CELL; MORPHOGENESIS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; POLYMERIZATION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; ANTIGENS, CD44; BONE AND BONES; BONE DEVELOPMENT; CARTILAGE; EXTRACELLULAR MATRIX; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; MORPHOGENESIS; SYNOVIAL MEMBRANE; TISSUE DISTRIBUTION;

EID: 38949123653     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7360-z     Document Type: Review

References (259)

1. Gribbon, P., Heng, B. C. and Hardingham, T. E. (1999) The molecular basis of the solution properties of hyaluronan investigated by confocal fluorescence recovery after photo-bleaching. Biophys. J. 77, 2210-2216.
2. Gribbon, P., Heng, B. C. and Hardingham, T. E. (2000) The analysis of intermolecular interactions in concentrated hyaluronan solutions suggest no evidence for chain-chain association. Biochem. J. 350, 329-335.
3. Almond, A., Brass, A. and and Sheehan, J. K. (1998) Deducing polymeric structure from aqueous molecular dynamics simulations of oligosaccharides: Predictions from simulations of hyaluronan tetrasaccharides compared with hydrodynamic and X-ray fibre diffraction data. J. Mol. Biol. 284, 1425-1437.
4. Almond, A., Brass, A. and Sheehan, J. K. (1998) Dynamic exchange between stabilized conformations predicted for hyaluronan tetrasaccharides: Comparison of molecular dynamics simulations with available NMR data. Glycobiology 8, 973-980.
5. Scott, J. E. and Heatley, F. (1999) Hyaluronan forms specific stable tertiary structures in aqueous solution: A 13C NMR study. Proc. Natl. Acad. Sci. U. S.A 96, 4850-4855.
6. Cooper, N. J., Mugford, M., Symmons, D. P., Barrett, E. M. and Scott, D. G. (2002) Total costs and predictors of costs in individuals with early inflammatory polyarthritis: A community-based prospective study. Rheumatology (Oxford) 41, 767-774.
7. Clarris, B. J. and Fraser, J. R. (1968) On the pericellular zone of somemammalian cells in vitro. Exp. Cell Res. 49, 181-193.
8. Underhill, C. B. and Toole, B. P. (1982) Transformation-dependent loss of the hyaluronate-containing coats of cultured cells. J. Cell Physiol. 110, 123-128.
9. Goldberg, R. L. and Toole, B. P. (1984) Pericellular coat of chick embryo chondrocytes: Structural role of hyaluronate. J. Cell Biol. 99, 2114-2122.
10. Knudson, C. B. and Toole, B. P. (1985) Changes in the pericellular matrix during differentiation of limb bud mesoderm. Dev. Biol. 112, 308-318.
11. McGuire, P. G., Castellot, J. J. Jr. and Orkin, R. W. (1987) Size-dependent hyaluronate degradation by cultured cells. J. Cell Physiol. 133, 267-276.
12. Knudson, W. and Knudson, C. B. (1991) Assembly of a chondrocyte-like pericellular matrix on non-chondrogenic cells. Role of the cell surface hyaluronan receptors in the assembly of a pericellular matrix. J. Cell Sci. 99, 227-235.
13. Heldin, P. and Pertoft, H. (1993) Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp. Cell Res. 208, 422-429.
14. Lu Valle, P., Iwamoto, M., Fanning, P., Pacifici, M. and Olsen, B. R. (1993) Multiple negative elements in a gene that codes for an extracellular matrix protein, collagen X, restrict expression to hypertrophic chondrocytes. J. Cell Biol. 121, 1173-1179.
15. Madry, H. and Trippel, S. B. (2000) Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. 7, 286-291.
16. Clarris, B. J. and Fraser, J. R. (1968) On the pericellular zone of somemammalian cells in vitro. Exp. Cell Res. 49, 181-193.
17. Knudson, W., Aguiar, D. J., Hua, Q. and Knudson, C. B. (1996) CD44-anchored hyaluronan-rich pericellular matrices: An ultrastructural and biochemical analysis. Exp. Cell Res. 228, 216-228.
18. Knudson, C. B. (1993) Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J. Cell Biol. 120, 825-834.
19. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelius, F. B., Gerth, U. and Bell, J. I. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 89, 12160-12164.
20. Yu, Q. and Toole, B. P. (1996) A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44. J. Biol Chem. 271, 20603-20607.
21. Salter, D. M., Godolphin, J. L., Gourlay, M. S., Lawson, M. F., Hughes, D. E. and Dunne, E. (1996) Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J. Pathol. 179, 396-402.
22. Knudson, C. B. and Knudson, W. (2004) Hyaluronan and CD44: Modulators of chondrocyte metabolism. Clin. Orthop. Relat. Res. S152-162.
23. Chow, G., Knudson, C. B., Homandberg, G. and Knudson, W. (1995) Increased expression of CD44 in bovine articular chondrocytes by catabolic cellular mediators. J. Biol. Chem. 270, 27734-27741.
24. Knudson, W., Casey, B., Nishida, Y., Eger, W., Kuettner, K. E. and Knudson, C. B. (2000) Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis. Arthritis Rheum. 43, 1165-1174.
25. Takahashi, K., Hashimoto, S., Kubo, T., Hirasawa, Y., Lotz, M. and Amiel, D. (2000) Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J. Rheumatol. 27, 1713-1720.
26. Lisignoli, G., Grassi, F., Zini, N., Toneguzzi, S., Piacentini, A., Guidolin, D., Bevilacqua, C. and Facchini, A. (2001) Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: Evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum. 44, 1800-1807.
27. Noonan, K. J., Stevens, J. W., Tammi, R., Tammi, M., Hernandez, J. A. and Midura, R. J. (1996) Spatial distribution of CD44 and hyaluronan in the proximal tibia of the growing rat. J. Orthop. Res. 14, 573-581.
28. Nakamura, H., Kenmotsu, S., Sakai, H. and Ozawa, H. (1995) Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tissue Res. 280, 225-233.
29. Fujii, Y., Fujii, K., Nakano, K. and Tanaka, Y. (2003) Crosslinking of CD44 on human osteoblastic cells upregulates ICAM-1 and VCAM-1. F. E. B. S. Lett. 539, 45-50.
30. Yamazaki, M., Nakajima, F., Ogasawara, A., Moriya, H., Majeska, R. J. and Einhorn, T. A. (1999) Spatial and temporal distribution of CD44 and osteopontin in fracture callus. J. Bone Joint Surg. Br. 81, 508-515.
31. Spessotto, P., Rossi, F. M., Degan, M., Di Francia, R., Perris, R., Colombatti, A. and Gattei, V. (2002) Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J. Cell Biol. 158, 1133-1144.
32. Sterling, H., Saginario, C. and Vignery, A. (1998) CD44 occupancy prevents macrophage multinucleation. J. Cell Biol. 143, 837-847.
33. Pavasant, P., Shizari, T. M. and Underhill, C. B. (1994) Distribution of hyaluronan in the epiphysial growth plate: Turnover by CD44-expressing osteoprogenitor cells. J. Cell Sci. 107, 2669-2677.
34. DeAngelis, P. L., Papaconstantinou, J. and Weigel, P. H. (1993) Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J. Biol Chem. 268, 19181-19184.
35. Dougherty, B. A. and van de Rijn, I. (1994) Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A steptococci. J. Biol. Chem. 269, 169-175.
36. Weigel, P. H., Hascall, V. C. and Tammi, M. (1997) Hyaluronan synthases. J. Biol. Chem. 272, 13997-14000.
37. Watanabe, K. and Yamaguchi, Y (1996) Molecular identification of a putative human hyaluronan synthase. J. Biol. Chem. 271, 22945-22948.
38. Spicer, A. P., Augustine, M. L. and McDonald, J. A. (1996) Molecular cloning and characterization of a putative mouse hyaluronan synthase. J. Biol. Chem. 271, 23400-23406.
39. Shyjan, A. M., Heldin, P., Butcher, E. C., Yoshino, T. and Briskin, M. J. (1996) Functional cloning of the cDNA for a human hyaluronan synthase. J. Biol. Chem. 271, 23395-23399.
40. Itano, N. and Kimata, K. (1996) Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase. J. Biol. Chem. 271, 9875-9878.
41. Itano, N. and Kimata, K. (1996) Molecular cloning of human hyaluronan synthase. Biochem. Biophys. Res. Commun. 222, 816-820.
42. Camenisch, T. D., Spicer, A. P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M. L., Calabro, A., Jr., Kubalak, S., Klewer, S. E. and McDonald, J. A. (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106, 349-360.
43. Walsh, E. C. and Stainier, D. Y. (2001) UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 293, 1670-1673.
44. Tien, J. Y. and Spicer, A. P. (2005) Three vertebrate hyaluronan synthases are expressed during mouse development in distinct spatial and temporal patterns. Dev. Dyn. 233, 130-141.
45. Hascall, V. C., Majors, A. K., De La Motte, C. A., Evanko, S. P., Wang, A., Drazba, J. A., Strong, S. A. and Wight, T. N. (2004) Intracellular hyaluronan: A new frontier for inflammation? Biochim. Biophys. Acta 1673, 3-12.
46. Schulz, T., Schumacher, U. and Prehm, P. (2007) Hyaluronan export by the A. B.C transporter M. R.P5 and its modulation by intracellular cGMP. J. Biol. Chem. 282, 20999-21004.
47. Recklies, A. D., White, C., Melching, L. and Roughley, P. J. (2001) Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem. J. 354, 17-24.
48. Goentzel, B. J., Weigel, P. H. and Steinberg, R. A. (2006) Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells. Biochem. J. 396, 347-354.
49. Itano, N., Sawai, T., Yoshida, M., Lenas, P., Yamada, Y., Imagawa, M., Shinomura, T., Hamaguchi, M., Yoshida, Y., Ohnuki, Y., Miyauchi, S., Spicer, A. P., McDonald, J. A. and Kimata, K. (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 274, 25085-25092.
50. Schiller, J., Fuchs, B., Arnhold, J. and Arnold, K. (2003) Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: Molecular pathways, diagnosis and potential therapeutic strategies. Curr. Med. Chem. 10, 2123-2145.
51. Csoka, A. B., Frost, G. I. and Stern, R. (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20, 499-508.
52. Lepperdinger, G., Mullegger, J. and Kreil, G. (2001) Hyal2 - less active, but more versatile? Matrix Biol. 20, 509-514.
53. Weigel, J. A. and Weigel, P. H. (2003) Characterization of the recombinant rat 175-kDa hyaluronan receptor for endocytosis (HARE). J. Biol. Chem. 278, 42802-42811.
54. Lesley, J., Hyman, R. and Kincade, P. W. (1993) CD44 and its interaction with extracellular matrix. Adv. Immunol. 54, 271-335.
55. Hayflick, J. S., Kilgannon, P. and Gallatin, W. M. (1998) The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions. Immunol. Res. 17, 313-327.
56. Turley, E. A., Belch, A. J., Poppema, S. and Pilarski, L. M. (1993) Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood 81, 446-453.
57. Banerji, S., Ni, J., Wang, S. X., Clasper, S., Su, J., Tammi, R., Jones, M. and Jackson, D. G. (1999) L.Y.V.E.-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789-801.
58. Bono, P., Rubin, K., Higgins, J. M. and Hynes, R. O. (2001) Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol. Biol. Cell 12, 891-900.
59. Lepperdinger, G., Strobl, B. and Kreil, G. (1998) HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem. 273, 22466-22470.
60. Chow, G., Knudson, C. B. and Knudson, W. (2006) Expression and cellular localization of human hyaluronidase-2 in articular chondrocytes and cultured cell lines. Osteoarthritis Cartilage 14, 849-858.
61. Stern, R (2003) Devising a pathway for hyaluronan catabolism: Are we there yet? Glycobiology 13, 105R-115R.
62. Mullegger, J. and Lepperdinger, G. (2002) Degradation of hyaluronan by a Hyal2-type hyaluronidase affects pattern formation of vitelline vessels during embryogenesis of Xenopus laevis. Mech. Dev. 111, 25-35.
63. Harada, H. and Takahashi, M. (2007) CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J. Biol. Chem. 282, 5597-5607.
64. Chow, G. and Knudson, W. (2005) Characterization of promoter elements of the human HYAL-2 gene. J. Biol. Chem. 280, 26904-26912.
65. + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem. 279, 26991-27007.
66. Rai, S. K., Duh, F. M., Vigdorovich, V., Danilkovitch-Miagkova, A., Lerman, M. I. and Miller, A. D. (2001) Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl. Acad. Sci. USA 98, 4443-4448.
67. Lokeshwar, V. B., Schroeder, G. L., Carey, R. I., Soloway, M. S. and Iida, N. (2002) Regulation of hyaluronidase activity by alternative mRNA splicing. J. Biol. Chem. 277, 33654-33663.
68. Csoka, A. B., Scherer, S. W. and Stern, R. (1999) Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics 60, 356-361.
69. Kim, E., Baba, D., Kimura, M., Yamashita, M., Kashiwabara, S. and Baba, T. (2005) Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. Proc. Natl. Acad. Sci. USA 102, 18028-18033.
70. Kim, E., Baba, D., Kimura, M., Yamashita, M., Kashiwabara, S. and Baba, T. (2005) Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. Proc. Natl. Acad. Sci. USA 102, 18028-18033.
71. Miller, K. A., Shao, M. and Martin-DeLeon, P. A. (2007) Hyalp1 in murine sperm function: Evidence for unique and overlapping functions with other reproductive hyaluronidases. J. Androl. 28, 67-76.
72. Reitinger, S., Laschober, G. T., Fehrer, C., Greiderer, B. and Lepperdinger, G. (2007) Mouse testicular hyaluronidase-like proteins SPAM1 and HYAL5 but not HYALP1 degrade hyaluronan. Biochem. J. 401, 79-85.
73. Baba, D., Kashiwabara, S., Honda, A., Yamagata, K., Wu, Q., Ikawa, M., Okabe, M. and Baba, T. (2002) Mouse sperm lacking cell surface hyaluronidase PH-20 can pass through the layer of cumulus cells and fertilize the egg. J. Biol. Chem. 277, 30310-30314.
74. Shuttleworth, T. L., Wilson, M. D., Wicklow, B. A., Wilkins, J. A. and Triggs-Raine, B. L. (2002) Characterization of the murine hyaluronidase gene region reveals complex organization and cotranscription of Hyal1 with downstream genes, Fus2 and Hyal3. J. Biol. Chem. 277, 23008-23018.
75. Stern, R. (2004) Hyaluronan catabolism: A new metabolic pathway. Eur. J. Cell Biol. 83, 317-325.
76. Stern, R., Asari, A. A. and Sugahara, K. N. (2006) Hyaluronan fragments: An information-rich system. Eur. J. Cell Biol. 85, 699-715.
77. Li, Y., Toole, B. P., Dealy, C. N. and Kosher, R. A. (2007) Hyaluronan in limb morphogenesis. Dev. Biol. 305, 411-420.
78. Oster, G. F., Murray, J. D. and Maini, P. K. (1985) A model for chondrogenic condensations in the developing limb: The role of extracellular matrix and cell tractions. J. Embryol. Exp. Morphol. 89, 93-112.
79. Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Pure, E., Henson, P. M. and Noble, P. W. (2002) Resolution of lung inflammation by CD44. Science 296, 155-158.
80. Dudhia, J. (2005) Aggrecan, aging and assembly in articular cartilage. Cell. Mol. Life Sci. 62, 2241-2256.
81. Roughley, P. J. (2006) The structure and function of cartilage proteoglycans. Eur. Cell Mater. 12, 92-101.
82. Mörgelin, M., Heinegård, D., Engel, J. and Paulsson, M. (1994) The cartilage proteoglycan aggregate: Assembly through combined protein-carbohydrate and protein-protein interactions. Biophys. Chem. 50, 113-128.
83. Hardingham, T. E. and Fosang, A. J. (1992) Proteoglycans: Many forms, many functions. FASEB J. 6, 861-870.
84. Holmes, M. W. A., Bayliss, M. T. and Muir, H. (1988) Hyaluronic acid in human articular cartilage. Biochem. J. 250, 435-441.
85. Bayliss, M. T. and Dudhia, J. (2002) Hyaluronan synthesis in human articular cartilage. In: Hyaluronan, vol. 2, pp. 297-302, Kennedy, J., Phillips, G., Williams, P. and Hascall, V. (eds.), MFK Group Ltd, Cambridge.
86. Pita, J. C., Muller, F. J., Manicourt, D. H., Buckwalter, J. A. and Ratcliffe, A. (1992) Early matrix changes in experimental osteoarthritis and joint disuse atrophy. In: Articular Cartilage and Osteoarthritis, pp. 455-470, Kuettner, K. E., Schleyerbach, R., Peyron, J. G. and Hascall, V. C. (eds.), Raven press, New York.
87. Hiscock, D. R., Caterson, B. and Flannery, C. R. (2000) Expression of hyaluronan synthases in articular cartilage. Osteoarthritis Cartilage 8, 120-126.
88. Ohno, S., Tanimoto, K., Fujimoto, K., Ijuin, C., Honda, K., Tanaka, N., Doi, T., Nakahara, M. and Tanne, K. (2001) Molecular cloning of rabbit hyaluronic acid synthases and their expression patterns in synovial membrane and articular cartilage. Biochim. Biophys. Acta 1520, 71-78.
89. Nishida, Y., Knudson, C. B., Nietfeld, J. J., Margulis, A. and Knudson, W. (1999) Antisense inhibition of hyaluronan synthase-2 in human articular chondrocytes inhibits proteoglycan retention and matrix assembly. J. Biol. Chem. 274, 21893-21899.
90. Schagemann, J. C., Mrosek, E. H., Landers, R., Kurz, H. and Erggelet, C. (2006) Morphology and function of ovine articular cartilage chondrocytes in 3-D hydrogel culture. Cells Tissues Organs 182, 89-97.
91. Takada, Y., Sakiyama, H., Kuriiwa, K., Masuda, R., Inoue, N., Nakagawa, K., Itano, N., Saito, T., Yamada, T. and Kimata, K. (1999) Metabolic activities of partially degenerated hypertrophic chondrocytes: Gene expression of hyaluronan synthases. Cell Tissue Res. 298, 317-325.
92. Lohmander, L. S., Dalen, N., Englund, G., Hamalainen, M., Jensen, E. M., Karlsson, K., Odensten, M., Ryd, L., Sernbo, I., Suomalainen, O. and Tegnander, A. (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: A randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann. Rheum. Dis. 55, 424-431.
93. Tamir, E., Robinson, D., Koren, R., Agar, G. and Halperin, N. (2001) Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: A randomized, double blind, placebo controlled study. Clin. Exp. Rheumatol. 19, 265-270.
94. Kydd, A. S., Reno, C. R., Tsao, H. W. and Hart, D. A. (2007) Early inflammatory arthritis in the rabbit: The influence of intraarticular and systemic corticosteroids on mRNA levels in connective tissues of the knee. J. Rheumatol. 34, 130-139.
95. Mrosek, E., Erggelet, C., McDonald, J. A. and Kurz, H. (2003) Hyaluronan synthases in normal and regenerating joint cartilage. Cells Tissues Organs 173, 93-104.
96. Flannery, C. R., Little, C. B., Hughes, C. E. and Caterson, B. (1998) Expression and activity of articular cartilage hyaluronidases. Biochem. Biophys. Res. Commun. 251, 824-829.
97. El Hajjaji, H., Cole, A. A. and Manicourt, D. H. (2005) Chondrocytes, synoviocytes and dermal fibroblasts all express P. H.-20, a hyaluronidase active at neutral pH. Arthritis Res. Ther. 7, R756-768.
98. Hua, Q., Knudson, C. B. and Knudson, W. (1993) Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J. Cell Sci. 106, 365-375.
99. Aguiar, D. J., Knudson, W. and Knudson, C. B. (1999) Internalization of the hyaluronan receptor CD44 by chondrocytes. Exp. Cell Res. 252, 292-302.
100. Embry, J. J. and Knudson, W. (2003) G1 domain of aggrecan cointernalizes with hyaluronan via a CD44-mediated mechanism in bovine articular chondrocytes. Arthritis Rheum. 48, 3431-3441.
101. Maroudas, A., Bayliss, M. T., Uchitel-Kaushansky, N., Schneiderman, R. and Gilav, E. (1998) Aggrecan turnover in human articular cartilage:Use of aspartic acid racemization as a marker of molecular age. Arch. Biochem. Biophys. 350, 61-71.
102. Verzijl, N., DeGroot, J., Bank, R. A., Bayliss, M. T., Bijlsma, J. W., Lafeber, F. P., Maroudas, A. and TeKoppele, J. M. (2001) Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: The use of pentosidine levels as a quantitative measure of protein turnover. Matrix Biol. 20, 409-417.
103. Morales, T. I. and Hascall, V. C. (1988) Correlated metabolism of proteoglycans and hyaluronic acid in bovine cartilage organ cultures. J. Biol. Chem. 263, 3632-3638.
104. Fosang, A. J., Tyler, J. A. and Hardingham, T. E. (1991) Effect of interleukin-1 and insulin-like growth factor-1 on the degradation and turnover of proteoglycan and hyaluronate in pig articular cartilage in explant culture. Matrix 11, 17-24.
105. Chockalingam, P. S., Zeng, W., Morris, E. A. and Flannery, C. R. (2004) Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2). Arthritis Rheum. 50, 2839-2848.
106. Campo, R. D. and Romano, J. E. (1986) Changes in cartilage proteoglycans associated with calcification. Calcif. Tissue Int. 39, 175-184.
107. Buckwalter, J. A., Rosenberg, L. C. and Ungar, R. (1987) Changes in proteoglycan aggregates during cartilage mineralization. Calcif. Tissue Int. 41, 228-236.
108. Sztrolovics, R., White, R. J., Roughley, P. J. and Mort, J. S. (2002) The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism. Biochem. J. 362, 465-472.
109. Sztrolovics, R., Recklies, A. D., Roughley, P. J. and Mort, J. S. (2002) Hyaluronate degradation as an alternative mechanism for proteoglycan release from cartilage during interleukin-1[beta]-stimulated catabolism. Biochem. J. 362, 473-479.
110. Plaas, A. H. K. and Sandy, J. D. (1993) A cartilage explant system for studies on aggrecan structure, biosynthesis and catabolism in discrete zones of the mammalian growth plate. Matrix 13, 135-147.
111. Yoshida, M., Sai, S., Marumo, K., Tanaka, T., Itano, N., Kimata, K. and Fujii, K. (2004) Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction. Arthritis Res. Ther. 6, 514-520.
112. Durigova, M., Roughley, P. J. and Mort, J. S. (2007) Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M. Osteoarthritis Cartilage (in press).
113. Sugimoto, K., Iizawa, T., Harada, H., Yamada, K., Katsumata, M. and Takahashi, M. (2004) Cartilage degradation independent of MMP/aggrecanases. Osteoarthritis Cartilage 12, 1006-1014.
114. Cheng, F., Heinegård, D., Fransson, L., Bayliss, M., Bielicki, J., Hopwood, J. and Yoshida, K. (1996) Variations in the chondroitin sulfate-protein linkage region of aggrecans from bovine nasal and human articular cartilages. J. Biol. Chem. 271, 28572-28580.
115. Yasumoto, T., Bird, J. L., Sugimoto, K., Mason, R. M. and Bayliss, M. T. (2003) The G1 domain of aggrecan released from porcine articular cartilage forms stable complexes with hyaluronan/ link protein. Rheumatology (Oxford) 42, 336-342.
116. Edwards, J. C., Wilkinson, L. S., Jones, H. M., Soothill, P., Henderson, K. J., Worrall, J. G. and Pitsillides, A. A. (1994) The formation of human synovial joint cavities: A possible role for hyaluronan and CD44 in altered interzone cohesion. J. Anat. 185, 355-367.
117. Balazs, E. A., Watson, D., Duff, I. F. and Roseman, S. (1967) Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum. 10, 357-376.
118. Pitsillides, A. A., Worrall, J. G., Wilkinson, L. S., Bayliss, M. T. and Edwards, J. C. (1994) Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br. J. Rheumatol. 33, 5-10.
119. Pitsillides, A. A., Will, R. K., Bayliss, M. T. and Edwards, J. C. (1994) Circulating and synovial fluid hyaluronan levels. Effects of intraarticular corticosteroid on the concentration and the rate of turnover. Arthritis Rheum. 37, 1030-1038.
120. Dahl, L. B., Dahl, I. M., Engstrom-Laurent, A. and Granath, K. (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann. Rheum. Dis. 44, 817-822.
121. Vuorio, E., Einola, S., Hakkarainen, S. and Penttinen, R. (1982) Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol. Int. 2, 97-102.
122. Wallis, W. J., Simkin, P. A., Nelp, W. B. and Foster, D. M. (1985) Intraarticular volume and clearance in human synovial effusions. Arthritis Rheum. 28, 441-449.
123. Balazs, E. A. and Denlinger, J. L. (1993) Viscosupplementation: A new concept in the treatment of osteoarthritis. J. Rheumatol. 20 Suppl. 39, 3-9.
124. Balazs, E. A. (2004) Viscosupplementation for treatment of osteoarthritis: From initial discovery to current status and results. Surg. Technol. Int. 12, 278-289.
125. Gomis, A., Pawlak, M., Balazs, E. A., Schmidt, R. F. and Belmonte, C. (2004) Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum. 50, 314-326.
126. Ohno, S., Im, H. J., Knudson, C. B. and Knudson, W. (2006) Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFkappaB. and p38 MAP kinase in articular chondrocytes. J. Biol. Chem. 281, 17952-17960.
127. Ohno, S., Im, H. J., Knudson, C. B. and Knudson, W. (2005) Hyaluronan oligosaccharide-induced activation of transcription factors in bovine articular chondrocytes. Arthritis Rheum. 52, 800-809.
128. Iacob, S. and Knudson, C. B. (2006) Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes. Int. J. Biochem. Cell Biol. 38, 123-133.
129. Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M. and Recker, R. R. (1987) Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610.
130. Sims, N. and Baron, R. (2000) Bone cells and their function. In: Skeletal Growth Factors, pp. 1-16, Canalis, E. (ed.), Lippincott Williams & Wilkins, Philadelphia.
131. Prince, C. W. (2004) Roles of hyaluronan in bone resorption. BMC Musculoskelet. Disord. 5, 12.
132. Stancikova, M., Svik, K., Istok, R., Rovensky, J. and, Velebny, V. (2004) The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Int. J. Tissue React. 26, 9-16.
133. Raisz, L. G. (1979) Physiological and pharmacologic regulation of bone resorption -A1978 update. J. Periodontol. 50, 3-6.
134. Ariyoshi, W., Takahashi, T., Kanno, T., Ichimiya, H., Takano, H., Koseki, T. and Nishihara, T. (2005) Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid. J. Biol. Chem. 280, 18967-18972.
135. Larjava, H., Mielityinen, H., Tenovuo, J., Jalkanen, M. and Paunio, K. (1982) The effect of human dental plaque on bone resorption and hyaluronic acid synthesis in in-vitro cultures of fetal rat calvaria. Arch. Oral. Biol. 27, 147-150.
136. 3H-glucosamine into hyaluronate in bone organ culture. Horm. Metab. Res. 10, 256-260.
137. Severson, A. R. (1979) Colchicine stimulation of hyaluronate synthesis and secretion in bone organ culture. J. Cell Physiol. 101, 341-348.
138. 3H-glucosamine into hyaluronate in bone organ cultures treated with dibutyryl cyclic AMP and colchicine. Exp. Cell Biol. 51, 70-76.
139. Chang, E. J., Kim, H. J., Ha, J., Ryu, J., Park, K. H., Kim, U. H., Lee, Z. H., Kim, H. M., Fisher, D. E. and Kim, H. H. (2007) Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J. Cell Sci. 120, 166-176.
140. Taylor, K. R., Yamasaki, K., Radek, K. A., Di Nardo, A., Goodarzi, H., Golenbock, D., Beutler, B. and Gallo, R. L. (2007) Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 282, 18265-18275.
141. Pilloni, A. and Bernard, G. W. (1998)The effect of hyaluronan on mouse intramembranous osteogenesis in vitro. Cell Tissue Res. 294, 323-333.
142. Huang, L., Cheng, Y. Y. , Koo, P. L., Lee, K. M. , Qin, L., Cheng, J. C. and Kumta, S. M. (2003) The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures. J. Biomed. Mater. Res. A 66, 880-884.
143. Nagahata, M., Tsuchiya, T., Ishiguro, T., Matsuda, N., Nakatsuchi, Y., Teramoto, A., Hachimori, A. and Abe, K. (2004) A novel function of N-cadherin and Connexin43: Marked enhancement of alkaline phosphatase activity in rat calvarial osteoblast exposed to sulfated hyaluronan. Biochem. Biophys. Res. Commun. 315, 603-611.
144. Itoh, S., Matubara, M., Kawauchi, T., Nakamura, H., Yukitake, S., Ichinose, S. and Shinomiya, K. (2001) Enhancement of bone ingrowth in a titanium fiber mesh implant by rhBMP-2 and hyaluronic acid. J. Mater. Sci. Mater. Med. 12, 575-581.
145. Sasaki, T. and Watanabe, C. (1995) Stimulation of osteoinduction in bone wound healing by high-molecular hyaluronic acid. Bone 16, 9-15.
146. Cho, B. C., Park, J. W., Baik, B. S., Kwon, I. C. and Kim, I. S. (2002) The role of hyaluronic acid, chitosan, and calcium sulfate and their combined effect on early bony consolidation in distraction osteogenesis of a canine model. J. Craniofac. Surg. 13, 783-793.
147. Cochran, D. L., Wisner, L. A., Richards, M. F. and Rouse, C. A. (1990) The induction of specific metabolic alterations in mouse calvarial organ cultures by glycosaminoglycans. Arch. Oral. Biol. 35, 515-522.
148. Hurley, M. M., Kream, B. E. and Raisz, L. G. (1990) Structural determinants of the capacity of heparin to inhibit collagen synthesis in 21-day fetal rat calvariae. J. Bone Miner. Res. 5, 1127-1133.
149. Wong, G. L. (1984) Paracrine interactions in bone-secreted products of osteoblasts permit osteoclasts to respond to parathyroid hormone. J. Biol. Chem. 259, 4019-4022.
150. Cao, J. J., Singleton, P. A., Majumdar, S., Boudignon, B., Burghardt, A., Kurimoto, P., Wronski, T. J., Bourguignon, L. Y. and Halloran, B. P. (2005) Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J. Bone Miner. Res. 20, 30-40.
151. Zou, L. J., Zou, X. N., Li, H., Mygind, T., Kassem, M. and Binger, C. (2007) The effect of hyaluronan on osteogenic differentiation of porcine bone marrow stromal cells in vitro. Int. J. Cancer 32, 500.
152. Tsukahara, S., Ikeda, R., Goto, S., Yoshida, K., Mitsumori, R., Sakamoto, Y., Tajima, A., Yokoyama, T., Toh, S., Furukawa, K. and Inoue, I. (2006) Tumour necrosis factor alpha-stimulated gene-6 inhibits osteoblastic differentiation of human mesenchymal stem cells induced by osteogenic differentiation medium and BMP-2. Biochem. J. 398, 595-603.
153. Waddington, R. J., Embery, G. and Last, K. S. (1989) Glycosaminoglycans of human alveolar bone. Arch Oral. Biol. 34, 587-589.
154. Prince, C. W. and Navia, J. M. (1983) Glycosaminoglycan alterations in rat bone due to growth and fluorosis. J. Nutr. 113, 1576-1582.
155. Vogel, H. G. (1979) Influence of maturation and aging on mechanical and biochemical parameters of rat bone. Gerontology 25, 16-23.
156. Dickson, I. R. and Roughley, P. J. (1993) The effects of vitamin D deficiency on proteoglycan and hyaluronate constituents of chick bone. Biochim. Biophys. Acta 1181, 15-22.
157. Kent, G. N., Walker, D. G. and Cohn, D. V. (1979) Decreased response to calcitonin in osteopetrotic microphthalmic mouse bone. Nature 280, 71-72.
158. Genever, P. G. and Dickson, I. R. (1996) Influence of vitamin D status on hyaluronan localization in bone. Bone 18, 429-435.
159. Oohira, A. and Nogami, H. (1989) Elevated accumulation of hyaluronate in the tubular bones of osteogenesis imperfecta. Bone 10, 409-413.
160. Burkhardt, R., Kettner, G., Bohm, W., Schmidmeier, M., Schlag, R., Frisch, B., Mallmann, B., Eisenmenger, W. and Gilg, T. (1987) Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 8, 157-164.
161. Toole, B. P., Biswas, C. and Gross, J. (1979) Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc. Natl. Acad. Sci. USA 76, 6299-6303.
162. Banerjee, S. D. and Toole, B. P. (1992) Hyaluronan-binding protein in endothelial cell morphogenesis. J. Cell Biol. 119, 643-652.
163. Toole, B. P., Turner, R. E. and Banerjee, S. D. (1993) Hyaluronan-binding protein in chondrogenesis and angiogenesis in the developing limb. Prog. Clin. Biol. Res. 383B, 437-444.
164. Borselli, C., Oliviero, O., Battista, S., Ambrosio, L. and Netti, P. A. (2007) Induction of directional sprouting angiogenesis by matrix gradients. J. Biomed. Mater. Res. A 80, 297-305.
165. West, D. C., Hampson, I. N., Arnold, F. and Kumar, S (1985) Angiogenesis induced by degradation products of hyaluronic acid. Science 228, 1324-1326.
166. West, D. C. and Kumar, S. (1989) The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res. 183, 179-196.
167. Slevin, M., West, D., Kumar, P., Rooney, P. and Kumar, S. (2004) Hyaluronan, angiogenesis and malignant disease. Int. J. Cancer 109, 793-794; author reply 795-796.
168. Taylor, K. R., Trowbridge, J. M., Rudisill, J. A., Termeer, C. C., Simon, J. C. and Gallo, R. L. (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279, 17079-17084.
169. Lokeshwar, V. B., Lokeshwar, B. L., Pham, H. T. and Block, N. L. (1996) Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res. 56, 651-657.
170. Slevin, M., Krupinski, J., Kumar, S. and Gaffney, J. (1998) Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab. Invest. 78, 987-1003.
171. Gao, F., Okunieff, P., Han, Z., Ding, I., Wang, L., Liu, W., Zhang, J., Yang, S., Chen, J., Underhill, C. B., Kim, S. and Zhang, L. (2005) Hypoxia-induced alterations in hyaluronan and hyaluronidase. Adv. Exp. Med. Biol. 566, 249-256.
172. Yee, A. J., Bae, H. W., Friess, D., Robbin, M., Johnstone, B. and Yoo, J. U. (2003) Augmentation of rabbit posterolateral spondylodesis using a novel demineralized bone matrix-hyaluronan putty. Spine 28, 2435-2440.
173. Midura, R. J., Su, X., Morcuende, J. A., Tammi, M. and Tammi, R. (2003) Parathyroid hormone rapidly stimulates hyaluronan synthesis by periosteal osteoblasts in the tibial diaphysis of the growing rat. J. Biol. Chem. 278, 51462-51468.
174. Wong, G. L., Luben, R. A. and Cohn, D. V. (1977) 1,25- Dihydroxycholecalciferol and parathormone: Effects on isolated osteoclast-like and osteoblast-like cells. Science 197, 663-665.
175. Wong, G. L. (1979) Basal activities and hormone responsiveness of osteoclast-like and osteoblast-like bone cells are regulated by glucocorticoids. J. Biol. Chem. 254, 6337-6340.
176. Chopra, R. K., Li, Z. M., Vickery, S. and Anastassiades, T. (1990) Newly synthesized proteoglycans secreted by sequentially derived populations of cells from new-born rat calvaria: Effects of transforming growth factor-beta and matrigenin activity. Cell Differ. Dev. 32, 47-59.
177. Luben, R. A., Wong, G. L. and Cohn, D. V. (1976) Biochemical characterization with parathormone and calcitonin of isolated bone cells: Provisional identification of osteoclasts and osteoblasts. Endocrinology 99, 526-534.
178. Fedarko, N. S., Termine, J. D., Young, M. F. and Robey, P. G. (1990) Temporal regulation of hyaluronan and proteoglycan metabolism by human bone cells in vitro. J. Biol. Chem. 265, 12200-12209.
179. Anastassiades, T. P. and Chan, C. (1993) Stimulatory effect of T. G.F-beta on anionic glycoconjugate synthesis by rat calvarial cells: Specificity, uncoupling of cell density dependence, and modulation by chondroitin sulfate. J. Bone Miner. Res. 8, 1301-1309.
180. Midura, R. J., Evanko, S. P. and Hascall, V. C. (1994) Parathyroid hormone stimulates hyaluronan synthesis in an osteoblast-like cell line. J. Biol. Chem. 269, 13200-13206.
181. Aubin, J. E., Heersche, J. N., Merrilees, M. J. and Sodek, J. (1982) Isolation of bone cell clones with differences in growth, hormone responses, and extracellular matrix production. J. Cell Biol. 92, 452-461.
182. Clarkin, C. E., Allen, S. J., Wheeler, B., Wheeler-Jones, C. P. D. and Pitsillides, A. A. (2007) UGDH. is a positive modulator of chondrogenesis. Int. J. Exp. Pathol. in press.
183. Vigetti, D., Ori, M., Viola, M., Genasetti, A., Karousou, E., Rizzi, M., Pallotti, F., Nardi, I., Hascall, V. C., De Luca, G. and Passi, A. (2006) Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis. J. Biol. Chem. 281, 8254-8263.
184. Ogawa, Y., Sawamura, S. J., Ksander, G. A., Armstrong, R. M., Pratt, B. M. and McPherson, J. M. (1990) Transforming growth factors-beta1 and beta2 induce synthesis and accumulation of hyaluronate and chondroitin sulfate in vivo. Growth factors 3, 53 -62.
185. Hunter, G. K., Heersche, J. N. and Aubin, J. E. (1983) Isolation of three species of proteoglycan synthesized by cloned bone cells. Biochemistry 22, 831-837.
186. Boskey, A. L. and Dick, B. L. (1991) Hyaluronan interactions with hydroxyapatite do not alter in vitro hydroxyapatite crystal proliferation and growth. Matrix 11, 442-446.
187. Adams, J. R., Sander, G. and Byers, S. (2006) Expression of hyaluronan synthases and hyaluronidases in the M. G.63 osteoblast cell line. Matrix Biol. 25, 40-46.
188. Nishida, Y., Knudson, W., Knudson, C. B. and Ishiguro, N. (2005) Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity. Exp. Cell Res. 307, 194-203.
189. Pitsillides, A. A. and Lanyon, L. E. (1998) Mechanical strain-associated N. O. production by bone cells. In: Nitric oxide in bone and joint diseases, pp. 151-168, Hukkanen, M. V. J., Polak, J. M. and Hughes, S. P. F. (eds.), Cambridge University Press, Cambridge.
190. Reilly, G. C., Haut, T. R., Yellowley, C. E., Donahue, H. J. and Jacobs, C. R. (2003) Fluid flow induced PGE2 release by bone cells is reduced by glycocalyx degradation whereas calcium signals are not. Biorheology 40, 591-603.
191. Magee, C., Nurminskaya, M. and Linsenmayer, T. F. (2001) U. D.P-glucose pyrophosphorylase: Up-regulation in hypertrophic cartilage and role in hyaluronan synthesis. Biochem. J. 360, 667-674.
192. Vincent, T., Molina, L., Espert, L. and Mechti, N. (2003) Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma. Br. J. Haematol. 121, 259-269.
193. Calabro, A., Oken, M. M., Hascall, V. C. and Masellis, A. M. (2002) Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: Predominant expression of H. A.S1 mRNA. and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients. Blood 100, 2578-2585.
194. Gallagher, J. T., Spooncer, E. and Dexter, T. M. (1983) Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J. Cell Sci. 63, 155-171.
195. Vaes, G. (1967) Hyaluronidase activity in lysosomes of bone tissue. Biochem. J. 103, 802-804.
196. Vaes, G. and Jacques, P. (1965) Studies on bone enzymes. The assay of acid hydrolases and other enzymes in bone tissue. Biochem. J. 97, 380-388.
197. Adams, J. R. J. and Byers, S. (2005) Hyaluronan metabolism in the M. G.63 osteoblast cell line. In: Hyaluronan: Its structure, metabolism, biological activities and therapeutic applications, vol. 2, pp. 459-463, Balazs, E. A. and Hascall, V. C. (eds.), Winmar Enterprises, Edgewater.
198. Deed, R., Rooney, P., Kumar, P., Norton, J. D., Smith, J., Freemont, A. J. and Kumar, S. (1997) Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int. J. Cancer 71, 251-256.
199. Baylink, D., Wergedal, J. and Thompson, E. (1972) Loss of protein polysaccharides at sites where bone mineralization is initiated. J. Histochem. Cytochem. 20, 279-292.
200. Toole, B. P., Jackson, G. and Gross, J. (1972) Hyaluronate in morphogenesis: Inhibition of chondrogenesis in vitro. Proc. Natl. Acad. Sci. U. S.A 69, 1384-1386.
201. Kosher, R. A., Savage, M. P. and Walker, K. H. (1981) A gradation of hyaluronate accumulation along the proximodistal axis of the embryonic chick limb bud. J. Embryol. Exp. Morphol. 63, 85-98.
202. Rousche, K. T. and Knudson, C. B. (2002) Temporal expression of CD44 during embryonic chick limb development and modulation of its expression with retinoic acid. Matrix Biol. 21, 53-62.
203. Knudson, C. B. and Toole, B. P. (1987) Hyaluronate-cell interactions during differentiation of chick embryo limb mesoderm. Dev. Biol. 124, 82-90.
204. Maleski, M. P. and Knudson, C. B. (1996) Hyaluronan-mediated aggregation of limb bud mesenchyme and mesenchymal condensation during chondrogenesis. Exp. Cell Res. 225, 55-66.
205. Kulyk, W. M. and Kosher, R. A. (1987) Temporal and spatial analysis of hyaluronidase activity during development of the embryonic chick limb bud. Dev. Biol. 120, 535-541.
206. Nicoll, S. B., Barak, O., Csoka, A. B., Bhatnagar, R. S. and Stern, R. (2002) Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem. Biophys. Res. Commun. 292, 819-825.
207. Kaya, G., Rodriguez, I., Jorcano, J. L., Vassalli, P. and Stamenkovic, I. (1997) Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolismin the skin and impairs keratinocyte proliferation. Genes Dev. 11, 996-1007.
208. Zoller, M., Herrmann, K., Buchner, S., Seiter, S., Claas, C., Underhill, C. B. and Moller, P. (1997) Transient absence of CD44 expression and delay in development by anti-CD44 treatment during ontogeny: A surrogate of an inducible knockout? Cell Growth Differ. 8, 1211-1223.
209. Protin, U., Schweighoffer, T., Jochum, W. and Hilberg, F. (1999) CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J. Immunol. 163, 4917-4923.
210. Archer, C. W., Morrison, H. and Pitsillides, A. A. (1994) Cellular aspects of the development of diarthrodial joints and articular cartilage. J. Anat. 184, 447-456.
211. Edwards, J. C., Wilkinson, L. S., Jones, H. M., Soothill, P., Henderson, K. J., Worrall, J. G. and Pitsillides, A. A. (1994) The formation of human synovial joint cavities: A possible role for hyaluronan and CD44 in altered interzone cohesion. J. Anat. 185, 355-367.
212. Pitsillides, A. A., Archer, C. W., Prehm, P., Bayliss, M. T. and Edwards, J. C. (1995) Alterations in hyaluronan synthesis during developing joint cavitation. J. Histochem. Cytochem. 43, 263-273.
213. Abu-Hijleh, G., Reid, O. and Scothorne, R. J. (1997) Cell death in the developing chick knee joint: I. Spatial and temporal patterns. Clin. Anat. 10, 183-200.
214. Mitrovic, D. (1978) Development of the diarthrodial joints in the rat embryo. Am. J. Anat. 151, 475-485.
215. Kavanagh, E., Abiri, M., Bland, Y. S. and Ashhurst, D. E. (2002) Division and death of cells in developing synovial joints and long bones. Cell Biol. Int. 26, 679-688.
216. Ito, M. M. and Kida, M. Y. (2000) Morphological and biochemical re-evaluation of the process of cavitation in the rat knee joint: Cellular and cell strata alterations in the interzone. J. Anat. 197, 659-679.
217. Pitsillides, A. A. (2006) Early effects of embryonic movement: 'A shot out of the dark'. J. Anat. 208, 417-431.
218. Osborne, A. C., Lamb, K. J., Lewthwaite, J. C., Dowthwaite, G. P. and Pitsillides, A. A. (2002) Short-term rigid and flaccid paralyses diminish growth of embryonic chick limbs and abrogate joint cavity formation but differentially preserve pre-cavitated joints. J. Musculoskelet. Neuronal. Interact. 2, 448-456.
219. Dowthwaite, G. P., Flannery, C. R., Flannelly, J., Lewthwaite, J. C., Archer, C. W. and Pitsillides, A. A. (2003) A mechanism underlying the movement requirement for synovial joint cavitation. Matrix Biol. 22, 311-322.
220. Dowthwaite, G. P., Ward, A. C., Flannely, J., Suswillo, R. F., Flannery, C. R., Archer, C. W. and Pitsillides, A. A. (1999) The effect of mechanical strain on hyaluronan metabolism in embryonic fibrocartilage cells. Matrix Biol. 18, 523-532.
221. Hunziker, E. B., Schenk, R. K. and Cruz-Orive, L. M. (1987) Quantitation of chondrocyte performance in growth-plate cartilage during longitudinal bone growth. J. Bone Joint Surg. Am. 69, 162-173.
222. Buckwalter, J. A. (1983) Proteoglycan structure in calcifying cartilage. Clin. Orthop. Relat. Res. 207-232.
223. Pavasant, P., Shizari, T. and Underhill, C. B. (1996) Hyaluronan contributes to the enlargement of hypertrophic lacunae in the growth plate. J. Cell Sci. 109, 327-334.
224. Alini, M., Matsui, Y., Dodge, G. R. and Poole, A. R. (1992) The extracellular matrix of cartilage in the growth plate before and during calcification: Changes in composition and degradation of type I. I. collagen. Calcif. Tissue Int. 50, 327-335.
225. Mwale, F., Tchetina, E., Wu, C. W. and Poole, A. R. (2002) The assembly and remodeling of the extracellular matrix in the growth plate in relationship to mineral deposition and cellular hypertrophy: An in situ study of collagens II and IX and proteoglycan. J. Bone Miner. Res. 17, 275-283.
226. Suzuki, A., Tanimoto, K., Ohno, S., Nakatani, Y., Honda, K., Tanaka, N., Doi, T., Ohno-Nakahara, M., Yoneno, K., Ueki, M. and Tanne, K. (2005) The metabolism of hyaluronan in cultured rabbit growth plate chondrocytes during differentiation. Biochim. Biophys. Acta 1743, 57-63.
227. Tanimoto, K., Suzuki, A., Ohno, S., Honda, K., Tanaka, N., Doi, T., Nakahara-Ohno, M., Yoneno, K., Nakatani, Y., Ueki, M., Yanagida, T., Kitamura, R. and Tanne, K. (2004) Hyaluronidase expression in cultured growth plate chondrocytes during differentiation. Cell Tissue Res. 318, 335-342.
228. Lohmander, S. and Hjerpe, A. (1975) Proteoglycans of mineralizing rib and epiphyseal cartilage. Biochim. Biophys. Acta 404, 93-109.
229. Franzen, A., Heinegard, D., Reiland, S. and Olsson, S. E. (1982) Proteoglycans and calcification of cartilage in the femoral head epiphysis of the immature rat. J. Bone Joint Surg. Am. 64, 558-566.
230. Boyde, A. and Shapiro, I. M. (1980) Energy dispersive X-ray elemental analysis of isolated epiphyseal growth plate chondrocyte fragments. Histochemistry 69, 85-94.
231. Thyberg, J., Lohmander, S. and Friberg, U. (1973) Electron microscopic demonstration of proteoglycans in guinea pig epiphyseal cartilage. J. Ultrastruct. Res. 45, 407-427.
232. Howell, D. S. and Carlson, L (1968) Alterations in the composition of growth cartilage septa during calcification studied by microscopic x-ray elemental analysis. Exp. Cell Res. 51, 185-195.
233. Poole, A. R., Pidoux, I. and Rosenberg, L. (1982) Role of proteoglycans in endochondral ossification: Immunofluorescent localization of link protein and proteoglycanmonomer in bovine fetal epiphyseal growth plate. J. Cell Biol. 92, 249-260.
234. Scherft, J. P. and Moskalewski, S. (1984) The amount of proteoglycans in cartilage matrix and the onset of mineralization. Metab. Bone Dis. Relat. Res. 5, 195-203.
235. Hargest, T. E., Gay, C. V., Schraer, H. and Wasserman, A. J. (1985) Vertical distribution of elements in cells and matrix of epiphyseal growth plate cartilage determined by quantitative electron probe analysis. J. Histochem. Cytochem. 33, 275-286.
236. Matsui, Y., Alini, M., Webber, C. and Poole, A. R. (1991) Characterization of aggregating proteoglycans from the proliferative, maturing, hypertrophic, and calcifying zones of the cartilaginous physis. J. Bone Joint Surg. Am. 73, 1064-1074.
237. Little, C. B., Meeker, C. T., Hembry, R. M., Sims, N. A., Lawlor, K. E., Golub, S. B., Last, K. and Fosang, A. J. (2005) Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development. Mol. Cell. Biol. 25, 3388-3399.
238. Little, C. B., Meeker, C. T., Golub, S. B., Lawlor, K. E., Farmer, P. J., Smith, S. M. and Fosang, A. J. (2007) Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J. Clin. Invest. 117, 1627-1636.
239. Glasson, S. S., Askew, R., Sheppard, B., Carito, B., Blanchet, T., Ma, H. L., Flannery, C. R., Peluso, D., Kanki, K., Yang, Z., Majumdar, M. K. and Morris, E. A. (2005) Deletion of active ADAMTS5 prevents cartilage degradation in amurine model of osteoarthritis. Nature 434, 644-648.
240. Glasson, S. S., Askew, R., Sheppard, B., Carito, B. A., Blanchet, T., Ma, H. L., Flannery, C. R., Kanki, K., Wang, E., Peluso, D., Yang, Z., Majumdar, M. K. and Morris, E. A. (2004) Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 50, 2547-2558.
241. Stanton, H., Rogerson, F. M., East, C. J., Golub, S. B., Lawlor, K. E., Meeker, C. T., Little, C. B., Last, K., Farmer, P. J., Campbell, I. K., Fourie, A. M. and Fosang, A. J. (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648-652.
242. Rogerson, F. M., East, C. J., Golub, S. B., Stanton, H. and Fosang, A. J. (2007) Aggrecan catabolism in mice lacking both ADAMTS-4 and ADAMTS-5 activities: Evidence for another aggrecanase in cartilage. Trans. Orthop. Res. Soc. 32, 82.
243. Lee, E. R. (2006) Proteolytic enzymes in skeletal development: Histochemical methods adapted to the study of matrix lysis during the transformation of a "cartilage model" into bone. Front. Biosci. 11, 2538-2553.
244. Lee, E. R., Lamplugh, L., Shepard, N. L. and Mort, J. S. (1995) The septoclast, a cathepsin B-rich cell involved in the resorption of growth plate cartilage. J. Histochem. Cytochem. 43, 525-536.
245. Griffiths, G. (2002) What's special about secretory lysosomes? Semin. Cell Dev. Biol. 13, 279-284.
246. Jaiswal, J. K., Andrews, N. W. and Simon, S. M. (2002) Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J. Cell Biol. 159, 625-635.
247. Reddy, A., Caler, E. V. and Andrews, N. W. (2001) Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell 106, 157-169.
248. McNeil, P. L. (2002) Repairing a torn cell surface: Make way, lysosomes to the rescue. J. Cell Sci. 115, 873-879.
249. Cocucci, E., Lorusso, A., Ongania, G. N., Klajn, A. and Meldolesi, J. (2006) Non-secretory exocytoses in the brain. J. Physiol. Paris 99, 140-145.
250. Meldolesi, J (2003) Surface wound healing: A new, general function of eukaryotic cells. J. Cell. Mol. Med. 7, 197-203.
251. Wang, P., Chicka, M. C., Bhalla, A., Richards, D. A. and Chapman, E. R. (2005) Synaptotagmin VII is targeted to secretory organelles in PC12 cells, where it functions as a high-affinity calcium sensor. Mol. Cell. Biol. 25, 8693-8702.
252. Bastow, E. R., Wilson, R., Golub, S. B. and Fosang, A. J. (2007) Lysosomal exocytosis in hypertrophic chondrocytes. Trans. Orthop. Res. Soc. 32, 593.
253. Sattar, A., Rooney, P., Kumar, S., Pye, D., West, D. C., Scott, I. and Ledger, P. (1994) Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J. Invest. Dermatol. 103, 576-579.
254. Slevin, M., Kumar, S. and Gaffney, J. (2002) Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J. Biol. Chem. 277, 41046-41059.
255. Rooney, P., Kumar, S., Ponting, J. and Wang, M. (1995) The role of hyaluronan in tumour neovascularization. Int. J. Cancer 60, 632-636.
256. Horner, A., Bishop, N. J., Bord, S., Beeton, C., Kelsall, A. W., Coleman, N. and Compston, J. E. (1999) Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J. Anat. 194, 519-524.
257. Montesano, R., Kumar, S., Orci, L. and Pepper, M. S. (1996) Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab. Invest. 75, 249-262.
258. Natowicz, M. R., Short, M. P., Wang, Y., Dickersin, G. R., Gebhardt, M. C., Rosenthal, D. I., Sims, K. B. and Rosenberg, A. E. (1996) Clinical and biochemical manifestations of hyaluronidase deficiency. N. Engl. J. Med. 335, 1029-1033.
259. Triggs-Raine, B., Salo, T. J., Zhang, H., Wicklow, B. A. and Natowicz, M. R. (1999) Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX. Proc. Natl. Acad. Sci. USA 96, 6296-6300.